Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

clinect nz pty limited - nadolol 80mg;  ;   - tablet - 80 mg - active: nadolol 80mg     excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - prophylaxis of angina pectoris

Canada - Engels - Health Canada

mint pharmaceuticals inc - nadolol - tablet - 80mg - nadolol 80mg - beta-adrenergic blocking agents

Canada - Engels - Health Canada

apotex inc - nadolol - tablet - 80mg - nadolol 80mg - beta-adrenergic blocking agents

Canada - Engels - Health Canada

teva canada limited - nadolol - tablet - 80mg - nadolol 80mg - beta-adrenergic blocking agents

Verenigd Koninkrijk - Engels - MHRA (Medicines & Healthcare Products Regulatory Agency)

neon healthcare ltd - nadolol - oral tablet - 80mg

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - nadolol 80mg - tablet - 80 mg - active: nadolol 80mg excipient: colloidal silicon dioxide croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose - prophylaxis of angina pectoris.

Verenigde Staten - Engels - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - nadolol (unii: fen504330v) (nadolol - unii:fen504330v) - nadolol 20 mg - nadolol tablets usp are indicated for the long-term management of patients with angina pectoris. nadolol tablets usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with nadolol tablets usp. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pres

Canada - Engels - Health Canada

ratiopharm inc division of teva canada limited - nadolol - tablet - 80mg - nadolol 80mg - beta-adrenergic blocking agents

Verenigde Staten - Engels - NLM (National Library of Medicine)

sandoz inc - nadolol (unii: fen504330v) (nadolol - unii:fen504330v) - nadolol 20 mg - nadolol tablets usp are indicated for the long-term management of patients with angina pectoris. nadolol tablets usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with nadolol tablets usp. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pres

Canada - Engels - Health Canada

apotex inc - nadolol - tablet - 160mg - nadolol 160mg - beta-adrenergic blocking agents